TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›ARGX

ARGX

ARGENX SE

Next earnings Jul 23, 2026 · consensus $6.27 EPS, $1.47B rev

Sell
$939.68
▲ +2.98%
$939.68▲ +67.76%
over 1Y
L $538.64H $939.68
Today+3.0%
1W+5.7%
1M+17.1%
3M+25.9%
YTD+11.9%
1Y+67.8%
OverviewValuationQualityFilings
Rating
Sell
Quality
A+
Valuation
Fair value
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 25 analysts
Buy

Mixed signals in the latest filings.

ARGENX SE shows limited reported revenue.

On these fundamentals, ARGX screens as SELL on the SEC figures.

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 10:20 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Financials · annual, by fiscal year

No income data filed.

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$58.7B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+1.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-06-232026-06-23open ↗6-KPeriod ending 2026-06-032026-06-03open ↗6-KPeriod ending 2026-05-082026-05-11open ↗6-KPeriod ending 2026-03-312026-05-07open ↗6-KPeriod ending 2026-05-062026-05-06open ↗SCHEDULE 13G/AFiling2026-05-06open ↗6-KPeriod ending 2026-04-202026-04-20open ↗6-KPeriod ending 2026-03-202026-03-20open ↗20-FPeriod ending 2025-12-312026-03-19open ↗6-KPeriod ending 2025-12-312026-03-19open ↗6-KPeriod ending 2026-03-062026-03-06open ↗6-KPeriod ending 2025-12-312026-02-26open ↗

Quality score

A+
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
MomentumA+
538.6452-week939.68
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals

Frequently asked

Is ARGENX SE (ARGX) a buy?
ARGX currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
What is ARGENX SE's quality score?
ARGX scores 92.98314446660675/100 (grade A+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001697862, latest 6-K filed 2026-06-23) · EODHD · as of 7/4/2026, 2:20:27 PM.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Congressional trades

all activity →

Disclosed under the STOCK Act

2023-08-13Daniel GoldmanSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Recent news

market news →
Robinhood, Dell Lead 5 Stocks Near Buy Points With AI TailwindsBullish
finance.yahoo.com· 2026-07-04
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent MemberBullish
finance.yahoo.com· 2026-07-02
Argenx, Stock Of The Day, Eyes Buy Point Amid Triple-Digit GrowthBullish
finance.yahoo.com· 2026-07-01
European Equities Traded in US as ADRs Rise in Thursday Trading
finance.yahoo.com· 2026-06-25
Can Argenx Retake Its Record High — And A Buy Point — On A New Vyvgart Strategy?
finance.yahoo.com· 2026-06-24
argenx to Host Autoimmune Myositis R&D WebinarBullish
finance.yahoo.com· 2026-06-23

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score93 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 26d
Bearish
-0.06
vs typical · 49 articles
↓ cooling

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.